CE Mark For Boston’s Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System

“The customized Platinum Chromium stent architecture maintains the superior visibility, exceptional radial strength and fracture resistance, minimal recoil and outstanding clinical outcomes of a PtCr Everolimus-Eluting stent while offering improved longitudinal strength”


Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval (via PR Newswire)

The Next Advance in Durable Polymer Stent Technology from Boston Scientific is Now Available in Europe and Other Select Geographies NATICK, Mass., Feb. 12, 2013 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the Promus PREMIER™ Everolimus-Eluting Platinum…